Xeris Biopharma Holdings (XERS)Director sold ~$120K

~$120K

Approx. value · 16K sh @ $7.72

142K

Holds after · shares reported

Traded

Sep 11, 2025

Filed

Sep 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 12, 2025InsiderDirector sold ~$309K of XERS shares in the open market
2. Aug 13, 2025InsiderDirector sold ~$786K of XERS shares in the open market
3. Aug 28, 2025InsiderDirector sold ~$335K of XERS shares in the open market
4. Sep 11, 2025 · this disclosureInsiderDirector sold ~$120K of XERS shares in the open market

What came next

1. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
2. Jan 8, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Xeris Biopharma Holdings

For Xeris Biopharma Holdings, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its XERS page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Xeris Biopharma Holdings

• SEC Form 4Oct 2, 2026
• SEC Form 4Oct 2, 2026
• SEC Form 4Oct 2, 2026
• SEC Form 4Sep 29, 2026
• SEC Form 4Aug 29, 2025
• SEC Form 4Aug 15, 2025

Everything OQRO holds on this company is on its XERS page.